Neukio develops allogenic immune cell therapies utilizing iPSC-derived CAR-NK technology to target and eliminate cancer cells. The company addresses the need for effective treatments against solid tumors by producing standardized, engineered NK cells at scale through in-house innovation and strategic partnerships.
Funding
Funding not disclosed
Founders
Product
Problem
Current CAR-T cell therapies face limitations in treating solid tumors due to challenges in tumor penetration, off-target effects, and the inability to produce them at scale. Autologous CAR-T therapies are also patient-specific, which increases manufacturing complexity and cost.
Solution
Neukio is developing allogeneic, iPSC-derived CAR-NK cell therapies designed to overcome the limitations of existing CAR-T therapies, particularly for solid tumors. By leveraging induced pluripotent stem cell (iPSC) technology, Neukio aims to produce a standardized, off-the-shelf CAR-NK cell product that can be manufactured at scale. These engineered NK cells are designed to target and eliminate cancer cells while minimizing off-target effects. The allogeneic approach allows for broader patient access and reduced manufacturing costs compared to autologous therapies.
Target Audience
The primary target audience includes patients with solid tumors who have failed to respond to existing therapies, as well as oncologists and hematologists seeking novel treatment options.
Features
- iPSC-derived NK cells engineered with CAR constructs for enhanced tumor targeting
- Allogeneic "off-the-shelf" product for immediate patient availability
- Scalable manufacturing process using iPSC technology for consistent product quality
- Enhanced NK cell functionality for improved tumor penetration and cytotoxicity
- Gene editing capabilities to further enhance NK cell properties and reduce rejection risk
- Preclinical and clinical development programs focused on solid tumor indications
- Proprietary NK cell expansion and differentiation protocols
- Three-tier cell bank system for quality control and consistency